Latest filing published 08 Jul 2021 for Dicerna Pharmaceuticals Inc, €44k.
Filing timeline
BuySaleInsider track record
Regina M. Paglia: trading record in brief
Regina M. Paglia is a declared insider of Dicerna Pharmaceuticals Inc (senior executive), with filings sourced from SEC (Form 4). The record holds 40 filings, for trades running from 4 November 2020 to 6 July 2021.
No open-market purchase appears, only 17 sales worth €3.0M. Outside the open market, there are 3 share grants and 20 option exercises. So far in 2021, the count stands at no purchases and 15 sales.
The latest filing, published on 8 July 2021, reports a share grant of €44k in Dicerna Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Regina M. Paglia
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,404 shares@ US$37.051.0% of flowCommon StockSEC:0001399529-21-000133:2
- 1,712 sharesCommon StockSEC:0001399529-21-000133:1
- 1,450 sharesCommon StockSEC:0001399529-21-000133:0
- 1,000 shares@ US$38.000.7% of flowCommon StockSEC:0001399529-21-000127:1
- 1,000 shares@ US$22.586.0% of flowCommon StockSEC:0001399529-21-000127:0
- 2,279 shares@ US$22.581.0% of flowCommon StockSEC:0001399529-21-000125:1
- 2,406 shares@ US$24.051.1% of flowCommon StockSEC:0001399529-21-000125:2
- 13,555 shares@ US$37.109.3% of flowCommon StockSEC:0001399529-21-000125:3
- 4,880 shares@ US$36.713.3% of flowCommon StockSEC:0001399529-21-000125:4
- 13,750 shares@ US$12.9347.6% of flowCommon StockSEC:0001399529-21-000125:0
- 4,000 shares@ US$24.051.8% of flowCommon StockSEC:0001399529-21-000123:1
- 8,664 shares@ US$35.795.7% of flowCommon StockSEC:0001399529-21-000123:2
- 4,664 shares@ US$12.9316.2% of flowCommon StockSEC:0001399529-21-000123:0
- 112 shares@ US$35.740.1% of flowCommon StockSEC:0001399529-21-000120:1
- 20,000 shares@ US$12.934.8% of flowCommon StockSEC:0001399529-21-000120:2
- 10,000 shares@ US$22.584.1% of flowCommon StockSEC:0001399529-21-000120:3
- 1,564 shares@ US$26.620.8% of flowCommon StockSEC:0001399529-21-000120:4
- 100 shares@ US$36.150.1% of flowCommon StockSEC:0001399529-21-000120:6
- 31,464 shares@ US$35.6320.6% of flowCommon StockSEC:0001399529-21-000120:5
- 381 sharesCommon StockSEC:0001399529-21-000120:0
- 4,126 shares@ US$30.862.3% of flowCommon StockSEC:0001399529-21-000093:1
- 305 shares@ US$31.970.2% of flowCommon StockSEC:0001399529-21-000093:2
- 4,431 shares@ US$12.9315.0% of flowCommon StockSEC:0001399529-21-000093:0
- 3,956 shares@ US$30.172.2% of flowCommon StockSEC:0001399529-21-000084:1
- 475 shares@ US$31.250.3% of flowCommon StockSEC:0001399529-21-000084:2
25 of 40 declarations
